The largest database of trusted experimental protocols

13 protocols using ly6g pe clone 1a8

1

Analyzing Immune Cell Populations in Transplanted Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples (~120 μL) were withdrawn from the facial vein of C57BL/6 (WT) recipient mice 8 weeks after transplantation with GFP+ bone marrow cells (GFP+/-→WT) (n = 15) as well as of GFP+/- (n = 9) and WT (n = 6) animals. Samples were quickly collected in EDTA-coated tubes (Starstedt, Montreal, Quebec, Canada) to prevent coagulation. A volume of 35 μL of DPBS without Ca2+ and Mg2+ (Sigma-Aldrich, St Louis, MO) was added to 65 μL of blood and incubated for 20 min on ice with purified rat anti-mouse CD16/CD32 antibody diluted 1:100 (clone 2.4G2; BD Biosciences) to block non-specific binding of IgGs to Fc receptors. Samples were washed and resuspended in 100 μL of DPBS after being centrifuged at 300 x g for 10 min. Cell suspensions were then labeled with the following rat anti-mouse antibodies for 40 min at 4°C: PE-Cy5-CD45 (clone 30-F11; BD Biosciences), APC-CD115 (clone AF598; eBioscience, San Diego, CA), PE-Cy7-CD11b (clone M1/70; eBioscience), V450-Ly6C (clone AL21; BD Biosciences) and PE-Ly6G (clone 1A8; BD Pharmingen, San Jose, CA). Red blood cells were lysed with BD Pharm Lyse™ (BD Biosciences) during 30 min at room temperature, and the recovered leukocytes were washed and resuspended in DPBS for analysis. Flow cytometry analysis and data acquisition were performed using a BD SORP LSR II and the BD FACSDiva software, respectively.
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry of Tumor Microenvironment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometric analysis of enzymatically digested tumor tissue was essentially performed as described in reference 65 (link). MRC1+ macrophages were gated as PE-Cy7 CD11b+ (clone M1/70 BD Bioscience), PE F4/80+ (clone BM8; BioLegend), and FITC CD206 (MRC1)+ (clone C068C2; BioLegend). Granulocytic myeloid-derived suppressor cells (GMDSC) were gated as PE-Cy7 CD11b+, PE Ly6-G+ (clone 1A8; BD Bioscience), and PerCP-Cy5.5 Ly6-Cint (clone Hk1.4; eBioscience). T cells were characterized as APC CD3+ (clone 17A2; eBioscience) and either eFluor 450 CD8a (clone 53-6.7; eBioscience) FITC CD4+ (clone GK1.5; BioLegend) for T-helper cells or vice versa for cytotoxic T cells. DAPI was used as a viability stain.
+ Open protocol
+ Expand
3

Quantitative Flow Cytometry of Blood Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to (day 0) and on days 4, 6, 8 and 10 following infection, blood samples (~120 μL) were drawn from the facial vein of CCR2-/-→WT and WT→CCR2-/- chimeric mice as well as age- and sex-matched WT and CCR2-/- controls (n = 5 mice per group). Samples were quickly collected in EDTA-coated tubes (Starstedt, Montreal, Quebec, Canada) to prevent coagulation. A volume of 35 μL of DPBS without Ca2+ and Mg2+ (Sigma-Aldrich) was added to 65 μL of blood and incubated for 20 min on ice with purified rat anti-mouse CD16/CD32 antibody diluted 1:100 (clone 2.4G2; BD Biosciences) to block non-specific binding of IgGs to Fc receptors. Samples were washed and resuspended in 100 μL of DPBS after being centrifuged at 300 x g for 10 min. Cell suspensions were then labeled with the following rat anti-mouse antibodies for 40 min at 4°C: PE-Cy5-CD45 (clone 30-F11; BD Biosciences), APC-CD115 (clone AF598; eBioscience, San Diego, CA), PE-Cy7-CD11b (clone M1/70; eBioscience), V450-Ly6C (clone AL21; BD Biosciences) and PE-Ly6G (clone 1A8; BD Pharmingen, San Jose, CA). Red blood cells were lysed with BD Pharm Lyse™ (BD Biosciences) for 30 min at room temperature, and the recovered leukocytes were washed and resuspended in DPBS. Flow cytometry analyses and data acquisition were performed using a BD SORP LSR II and the BD FACSDiva software, respectively.
+ Open protocol
+ Expand
4

Flow Cytometry Neutrophil Phagocytosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure phagocytosis of neutrophils by flow cytometry, wound cells were stained with Ly6C-FITC and F4/80-APC to identify macrophages and with Ly6G-V450 (clone 1A8; BD Bioscience) to exclude neutrophils. Cells were fixed and permeabilized as described above, then intracellularly stained with Ly6G-PE (clone 1A8; BD Biosciences). Doublets were excluded from analysis and isotype controls for surface and intracellular Ly6G antibodies were used to ensure specificity of intracellular Ly6G staining.
+ Open protocol
+ Expand
5

Ly6G Depletion in LPS Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-mouse Ly6G (300 μg; clone IA8; BP0075-1; BioXCell) or its isotype control rat IgG2a (clone 2A3; BP0089; BioXCell) in 1× PBS was administered via the i.p. route to LPS/saline mice. Antibody injections began the same day as LPS/saline injections and continued every 48 h. CFU numbers were assessed at 7 days of infection. Single-cell suspensions were isolated at day 0 (uninfected) and analyzed by flow cytometry to assess depletion efficiency. Intracellular Ly6G was used in place of surface Ly6G to account for potential surface antigen masking by the depletion antibody (70 (link)). After 2% PFA fixation, intracellular Ly6G was stained in the intracellular staining permeabilization wash buffer (BioLegend) using the manufacturer’s protocol. Ly6G antibodies (Ly6G, PE; clone 1A8; BD Pharmingen) used for intracellular staining were diluted half of what was typically used for surface staining.
+ Open protocol
+ Expand
6

Neutrophil Recruitment Analysis in Lungs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Leukocyte recruitment into lung tissue was analyzed by flow cytometry, and 100 μl containing 2 × 105 cells from homogenized lung tissue were used for each stain. Cells were centrifuged at 400 g for 2 min and resuspended in staining medium containing PBS, 4% bovine serum albumin (Sigma), and 0.1% sodium azide (Sigma). The following antibodies specific to mouse surface markers were used: Ly6G-PE (clone 1A8, BD Biosciences), CD11b-APC (BD Biosciences), and CD11c-PerCP (BD Biosciences). Isotype controls (BD Biosciences) and Fluorescent Minus One (FMO) control stains were performed. Flow cytometry analysis was performed on a FACSVerse (BD Biosciences) and analyzed with FlowJo software (Tree Star). The total leukocyte population was gated based on FSc and SSc and neutrophils were analyzed based on their specific expression of Ly6G and CD11b (Ly6GhighCD11bhiCD11clo population). Differential cell counts were calculated based on the percentage of neutrophils within the total leukocyte population.
+ Open protocol
+ Expand
7

Ly6G Depletion in LPS Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-mouse Ly6G (300 μg; clone IA8; BP0075-1; BioXCell) or its isotype control rat IgG2a (clone 2A3; BP0089; BioXCell) in 1× PBS was administered via the i.p. route to LPS/saline mice. Antibody injections began the same day as LPS/saline injections and continued every 48 h. CFU numbers were assessed at 7 days of infection. Single-cell suspensions were isolated at day 0 (uninfected) and analyzed by flow cytometry to assess depletion efficiency. Intracellular Ly6G was used in place of surface Ly6G to account for potential surface antigen masking by the depletion antibody (70 (link)). After 2% PFA fixation, intracellular Ly6G was stained in the intracellular staining permeabilization wash buffer (BioLegend) using the manufacturer’s protocol. Ly6G antibodies (Ly6G, PE; clone 1A8; BD Pharmingen) used for intracellular staining were diluted half of what was typically used for surface staining.
+ Open protocol
+ Expand
8

Enrichment and Sorting of Wound Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrophages were enriched from isolated wound cells by negative selection. Specifically, cells were stained with Ly6G-PE (clone 1A8; BD Biosciences), CD2-PE (clone RM2–5; BD Biosciences), TER119/Erythroid Cells-PE (clone Ter-119; BD Biosciences), and/or Siglec-F (MerTK−/− experiments; clone E50–2440; BD Biosciences) for ≤1 hour, washed, and incubated with anti-PE magnetic beads (Miltenyi Biotec) for 20 minutes. Cells were washed and eluted through a magnetic column (Miltenyi Biotec) to deplete non-monocyte/macrophage populations. Enriched monocytes/macrophages were assessed for viability by trypan blue exclusion and surface stained with Ly6C-FITC and F4/80-APC as described above. Eosinophils were identified as F4/80intSSChi and were excluded during sorting. Ly6ChiF4/80+ and Ly6ClowF4/80hi populations were sorted to greater than 90% purity under sterile conditions on a FACSAria (BD Biosciences). Sorted cells were assessed for viability by trypan blue exclusion, resuspended in complete medium (DMEM/5% FCS/Penicillin-Streptomycin) and cultured at 37°C/5% CO2.
+ Open protocol
+ Expand
9

Haematoxylin and Eosin Staining with Confocal Microscopy

Check if the same lab product or an alternative is used in the 5 most similar protocols
For haematoxylin and eosin (H&E) staining, whole ears were fixed in 10% formalin (Sigma) for 24 h and dehydrated into xylene (Pronalys) overnight in a tissue processor (Thermo Fisher Citadel 200). Paraffin wax embedded tissue was sectioned on a microtome at 3–4 μm onto adhesive microscope slides (Trajan). Sections were rehydrated and stained with hematoxylin and eosin as per manufacturer's instructions (Thermo Fisher). Sections were observed using an Olympus BX51TF compound microscope using a 10x, N.A. 0.3 objective, and images taken in the middle of the ear section.
For confocal microscopy, samples were processed and stained using a standard immunofluorescence protocol (37 (link)). Whole ears were incubated in 20% sucrose for 1 h and snap-frozen in OCT compound (Tissue-Tek) using a Stand-Alone Gentle Jane snap-freezing system (Leica Biosystems). Cryosections of 10 μm were fixed in cold acetone for 3 min and blocked with Fc Block (clone 2.4G2) for 1 h and stained with Ly6G-PE (clone 1A8, Pharmingen). For nuclear staining, sections were incubated with DAPI (2 mg/ml) for 10 min. Images were taken with an inverted IX 83 inverted microscope equipped with a FV1200 confocal head (Olympus) using a 20X, N.A. 0.75 objective. Images were acquired using the FV10-ASW software (v4.2b, Olympus) and processed with ImageJ (38 (link)).
+ Open protocol
+ Expand
10

Isolation and Analysis of Wound Macrophage Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrophages from the day 14 wound were enriched through negative selection on a magnetic column (Miltenyi Biotec) using the following depletion cocktail: Ly6G-PE (clone 1A8, BD Biosciences), CD2-PE (clone RM2–5; BD Biosciences), Siglec-F-PE (clone E50–2440; BD Biosciences) and TER119/Erythroid Cells-PE (clone Ter-119; BD Biosciences). Staining and column enrichment were carried out as previously described. Following enrichment, wound macrophages were surface stained with Ly6C-FITC, Ly6G-PE, Siglec-F-PE and F4/80-APC for 30 minutes on ice. Sytox Blue (Invitrogen) was used for dead cell exclusion. Ly6ChiF4/80+Ly6GSiglec-F and Ly6Clow/intF4/80+Ly6GSiglec-F subsets were sorted to ≥90% purity under sterile conditions using a FACSAria.
RNA was isolated from sorted cells using the RNeasy Micro Kit (Qiagen) and cDNA was synthesized with the High Capacity RNA-to-cDNA Kit (Life Technologies). Gene expression analysis was performed by real-time quantitative PCR on a ViiA 7 system (Life Technologies) using TaqMan Assays (Life Technologies) and TaqMan Gene Expression Master Mix (Life Technologies). TaqMan Assay IDs for individual genes are shown in Table S1. Hprt and 18 s served as endogenous controls. Both reference genes produced similar results after normalization. Results using Hprt are shown here. Analysis was carried out using the 2–ΔΔCt method.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!